TrophoMax LLC
We are an agricultural biotech company commercializing a patented natural seed & leaf inoculant based around a natural beneficial bacteria.
- Stage Product In Development
- Industry Biotechnology
- Location St. Louis, MO, USA
- Currency USD
- Founded September 2011
- Employees 5
- Website Trophomax.com
Company Summary
TrophoMax® is the brand name for a patented agricultural seed and leaf inoculant. The active ingredient is a naturally occurring family of beneficial bacteria known as PPFMs. In preliminary third party tests, when PPFMs have been applied to the seeds and leaves of certain plants, crop yield and biomass increases of 10% and higher have been observed. TrophoMax is the exclusive licensee of 6 US patents and the owner of two provisional patents.
Team
-
Thomas LauritaPresident and CEO
Thomas Laurita, MPPM/PhD, President and CEO: Entrepreneur with multiple successes growing technology, manufacturing, and financial companies from start-up to exit; 20+ years consulting experience for major agricultural multinationals; former USSR Country Manager for Monsanto.
-
Stephen KahnChief Financial Officer
Stephan Kahn MBA, Senior VP and CFO: Harvard MBA and with 17 years experience as Managing Director at Advent International (Private Equity/VC), 10 years High Tech management (CAD/CAM)
-
Marc VanachtVP for Business Development & Strategy
Marc Vanacht MBA/Master of Law, VP for Business Development and Strategy: Multicultural, Belgian citizen fluent in 5 languages with 20 years managerial experience in Monsanto; 15+ years as an strategic consultant, and an internationally recognized expert and advocate on technology innovation and precision agriculture.
-
Marcus JonesVP Product Development
Marcus Jones PhD, VP for Product Development: until July 2012 a top PD manager, most recently at Monsanto (5 years) and Syngenta (10 years) with PhD in Crop and Soil Science from Michigan State. Deep experience in multiple cropping systems, product evaluation, seed technology, biotic/abiotic yield and stress testing, agronomy, experimental trial design.
-
Michael BielskiVP for intellectual Property & Corp Counsel
Mike Bielski JD/MS, VP for Intellectual Property and Corporate Counsel: lawyer specialized in IP and patent strategy focused on biotech startups; molecular biology and neuroscience background.
-
Bernard AuxensfansAdvisory Board/Consultant
Bernard Auxenfans MS, Agricultural engineer, former COO of Monsanto Agriculture Worldwide; former President and Chairman of Monsanto Europe; a French citizen and acknowledged expert on the commercialization of agricultural inputs.
-
Dilip ShahAdvisory Board/ Consultant
Dilip Shah PhD, world-level geneticist, Monsanto Fellow, inventor on 13 relevant patents including original glyphosate resistance patents. 18 years as Monsanto scientist, from 2001-present Principal Investigator at Danforth Plant Sciences center.
-
Gregg BogosianAdvisory Board/ Consultant
Gregg Bogosian PhD, winner of the prestigious Queeny Award at Monsanto. 26 years at Monsanto as senior research scientist focused on microbial biology and production. Expert Patent Witness.
-
Mark HollandAdvisory Board
Mark Holland PhD, discoverer and patent author of the agricultural uses of PPFMs, Professor and former Chair of the Biology Department at Salisbury University (part of the University of Maryland system).
Advisors
-
Powell Carmen/ Brendan Johnson -- Bryan Cave; Rick Shear --Thompson CoburnLawyerUnconfirmedWalsh and Associates - Concord, MAAccountantUnconfirmed
Previous Investors
-
Angel Investors -- $850,000Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.